Canadian Sec - Delayed Quote CAD

NeuralThera (NURL.CN)

0.0350

+0.0050

+(16.67%)

At close: 3:50:44 PM EDT

Neural Therapeutics Announces RSU and Options Grant

Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, announces that the Board of Directors approved the grant of 2,720,000 restricted share units ("RSUs") and 725,000 stock options ("Options").RSUs were granted to directors and consultants of Neural in accordance with the provisions o

Newsfile 2 days ago

NURL.CN
+16.67%
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM

Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has submitted a renewal application to Servicio Nacional Forestal y de Fauna Silvestre ("SERFOR"). SERFOR a specialized Peruvian technical governmental agency under the Ministry of Agriculture, responsi

Newsfile 6 days ago

NURL.CN
+16.67%
Canadian Securities Exchange Reports March 2025 Performance Figures

Toronto, Ontario--(Newsfile Corp. - April 16, 2025) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for March 2025.March 2025 Operating StatisticsTrading volume of CSE listed securities totaled 1.1 billion shares;Trading value of CSE listed securities was $296 million;CSE issuers completed 85 financings that raised an aggregate $102 million; andThe CSE welcomed listings from two new companies, bringing total listed securities to 764 as at March 31,

Newsfile 29 days ago

ADON.CN

NURL.CN
+16.67%
Neural Therapeutics Strengthens IP Portfolio With a Patent Application

Treatment of Major DSM-5 Disorders, Including Addiction, Depression and Anxiety, With Sub-Hallucinogenic Mescaline DosesExtraction Technology Delivering Higher Yields and Greater PurityFrankfurt Stock Exchange Ticker Symbol Changed to "HANF"Extension of LOI with CWE European Holdings (dba Hanf.com) Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company dedicated to developing the

Newsfile last month

NURL.CN
+16.67%
Neural Therapeutics Commences Trading on Frankfurt Stock Exchange

Toronto, Ontario--(Newsfile Corp. - March 31, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: M6B) ("Neural" or the "Company"), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that shares of the company have commenced trading on the Frankfurt Stock Exchange under ticker symbol "M6B".Neural CEO Ian Campbell commented, "Listing our shares on a Frankfurt Stock Exchange will provide

Newsfile last month

NURL.CN
+16.67%

M6B.F
Canadian Securities Exchange Welcomes Listing of Neural Therapeutics Inc.

Toronto, Ontario--(Newsfile Corp. - March 17, 2025) - he Canadian Securities Exchange ("CSE" or "the Exchange") today welcomed the listing of Neural Therapeutics Inc. ("Neural Therapeutics" or the "Company"). The Toronto-based company has completed a private placement financing, and its common shares have been approved for listing on the CSE under the symbol NURL.Neural Therapeutics is a drug discovery and development company focused on harnessing the medical benefits of psychoactive plants, in

Newsfile last month

LURL.CN

NURL.CN
+16.67%
Neural Therapeutics Commences Trading, Provides Update on Growth Initiatives and Engages Investor Relations Consultants

Toronto, Ontario--(Newsfile Corp. - March 17, 2025) - Neural Therapeutics Inc. (CSE: NURL) ("Neural" or the "Company"), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that its common shares will commence trading on the Canadian Securities Exchange ("CSE") under the symbol "NURL" on Monday, March 17, 2025.With the listing process completed and the Series A Financing closed, Neural w

Newsfile last month

LURL.CN

NURL.CN
+16.67%

Performance Overview

Return	NURL.CN	S&P/TSX Composite index (^GSPTSE)
YTD	+16.67%	+5.19%
1-Year	+16.67%	+16.21%
3-Year	+16.67%	+28.84%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

NeuralThera (NURL.CN)

Neural Therapeutics Announces RSU and Options Grant

Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM

Canadian Securities Exchange Reports March 2025 Performance Figures

Neural Therapeutics Strengthens IP Portfolio With a Patent Application

Neural Therapeutics Commences Trading on Frankfurt Stock Exchange

Canadian Securities Exchange Welcomes Listing of Neural Therapeutics Inc.

Neural Therapeutics Commences Trading, Provides Update on Growth Initiatives and Engages Investor Relations Consultants

Performance Overview